Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Bershteyn

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Open Forum Infectious Diseases|September 29, 2025
Impacts of US Bilateral Aid Disruptions on HIV Resurgence in Zambia: A Mathematical Modeling StudyLloyd B Mulenga, Kebby Musokotwane, Suilanji Sivile, et al.
The Lancet. Global Health|August 12, 2022
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical modelsAnna Bershteyn, Lise Jamieson, Hae-Young Kim, et al.
Health & Place|June 2, 2019
Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern AfricaCarol S Camlin, Adam Akullian, Torsten B Neilands, et al.
Journal of the International AIDS Society|July 2, 2025
Estimated impact of long-acting injectable PrEP in South Africa: a model comparison analysisSarah E Stansfield, Mia Moore, Lise Jamieson, et al.
The Lancet. Global Health|September 20, 2015
Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy eraJeffrey W Eaton, Nicolas Bacaër, Anna Bershteyn, et al.
Clinical and Translational Science|April 29, 2023
A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS-CoV-2(-)/(+) populationsClaire Steinbronn, Yashpal S Chhonker, Jenell Stewart, et al.
The Lancet. HIV|August 11, 2020
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical modelsBritta L Jewell, Edinah Mudimu, John Stover, et al.
African Journal of AIDS Research : AJAR|August 21, 2025
HIV incidence and prevalence projections for Zimbabwe: Findings from five mathematical modelsIsaac Taramusi, John Stover, Robert Glaubius, et al.
The Lancet. Global Health|May 24, 2025
Identifying gaps in the HIV treatment cascade in Africa: a model comparison studyLoveleen Bansi-Matharu, Haroon Moolla, Daniel T Citron, et al.
Journal of Medical Virology|August 8, 2022
Using time-weighted average change from baseline of SARS-CoV-2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID-19Raaka Kumbhakar, Moni Neradilek, Ruanne V Barnabas, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Open Forum Infectious Diseases|September 29, 2025
Impacts of US Bilateral Aid Disruptions on HIV Resurgence in Zambia: A Mathematical Modeling StudyLloyd B Mulenga, Kebby Musokotwane, Suilanji Sivile, et al.
The Lancet. Global Health|August 12, 2022
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical modelsAnna Bershteyn, Lise Jamieson, Hae-Young Kim, et al.
Health & Place|June 2, 2019
Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern AfricaCarol S Camlin, Adam Akullian, Torsten B Neilands, et al.
Journal of the International AIDS Society|July 2, 2025
Estimated impact of long-acting injectable PrEP in South Africa: a model comparison analysisSarah E Stansfield, Mia Moore, Lise Jamieson, et al.
The Lancet. Global Health|September 20, 2015
Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy eraJeffrey W Eaton, Nicolas Bacaër, Anna Bershteyn, et al.
Clinical and Translational Science|April 29, 2023
A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS-CoV-2(-)/(+) populationsClaire Steinbronn, Yashpal S Chhonker, Jenell Stewart, et al.
The Lancet. HIV|August 11, 2020
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical modelsBritta L Jewell, Edinah Mudimu, John Stover, et al.
African Journal of AIDS Research : AJAR|August 21, 2025
HIV incidence and prevalence projections for Zimbabwe: Findings from five mathematical modelsIsaac Taramusi, John Stover, Robert Glaubius, et al.
The Lancet. Global Health|May 24, 2025
Identifying gaps in the HIV treatment cascade in Africa: a model comparison studyLoveleen Bansi-Matharu, Haroon Moolla, Daniel T Citron, et al.
Journal of Medical Virology|August 8, 2022
Using time-weighted average change from baseline of SARS-CoV-2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID-19Raaka Kumbhakar, Moni Neradilek, Ruanne V Barnabas, et al.
Pageof 10